Pfizer Annual Revenue Doubled – to $81.3 Billion – Thanks to COVID Vaccines

Close-Up Shot of a Covid Vaccine

Joseph Mercola The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, but it has also given the drugmaker unique weight in determining U.S. health policy … Pfizer’s COVID jab dominates 70% of the U.S. and European markets, and Paxlovid, its COVID drug, has become a standard […]